Shenzhou Cell (688520.SH): The registration certificate for the injection of Fennel Monoclonal Antibody has been obtained.

11/02/2025

GMT Eight

Shenzhou Cell (688520.SH) announced that its holding subsidiary Shenzhou Cell Engineering Co., Ltd. recently received the "Drug Registration Certificate" issued by the National Medical Products Administration for the approval of the injection of panitumumab (trade name: Anyouping), used in the treatment of head and neck squamous cell carcinoma.

BOCOM INTL: Industrial mother machine related data continues to improve, and the industry's prosperity in 2025 is expected to further increase.

Zhejiang Huahai Pharmaceutical (600521.SH) has adjusted the size of the private placement fundraising to not exceed 600 million yuan.

Contact: contact@gmteight.com

Shenzhou Cell (688520.SH): The registration certificate for the injection of Fennel Monoclonal Antibody has been obtained.

RECOMMEND

Austasia Group (02425) issued a profit warning, expecting the net loss for the 2024 financial year to increase by about 11.7 billion to 13.8 billion compared to the previous year.

The latest performance triggers reflections, Wall Street collectively optimistic about "small NVIDIA Corporation" Astera Labs (ALAB.US), AI prospects continue to shine.

Hong Kong Property Market: Hong Kong's second-hand residential registration volume exceeds 10 million Hong Kong dollars in January, with the highest proportion in 7 months.